For 1 in 250 people, IBD is an invisible burden, full of unpredictable moments and urgent needs. The condition affects daily life profoundly, but the stigma can feel even heavier. Lilly and CCV-vzw wanted to break the silence, spark open conversations, and give patients a platform to share their experiences.